StockNews.com began coverage on shares of Onconova Therapeutics (NASDAQ:ONTX – Free Report) in a report issued on Thursday morning. The firm issued a sell rating on the biopharmaceutical company’s stock.
Onconova Therapeutics Price Performance
The firm has a market cap of $20.90 million, a price-to-earnings ratio of -1.09 and a beta of 1.38. Onconova Therapeutics has a 12-month low of $0.55 and a 12-month high of $1.45. The firm’s 50-day moving average is $0.85 and its 200 day moving average is $0.74.
About Onconova Therapeutics
See Also
- Five stocks we like better than Onconova Therapeutics
- How to invest in marijuana stocks in 7 steps
- MarketBeat Week in Review – 4/29 – 5/3
- The Most Important Warren Buffett Stock for Investors: His Own
- Apple’s Earnings Show Investors Its Strength and Its Weakness
- Asset Allocation: The Key to a Successful Portfolio. Are You Paying Attention to Yours?
- Bargain Alert: 3 Large Caps With Extremely Oversold RSIs
Receive News & Ratings for Onconova Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Onconova Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.